PMID: 6110804Sep 15, 1980Paper

Electrophysiological classification of newer antiarrhythmic drugs (author's transl)

Klinische Wochenschrift
W Schmitz

Abstract

Newer antiarrhythmic drugs are tentatively classified on the basis of their influence on the transmembrane action potential, the fast sodium inward current and its kinetics, and the slow inward current which is primarily carried by calcium ions. Disopyramide is probably a quinidine-like antiarrhythmic drug, while the effects of aprindine, lorcainide, and tocainide resemble those of lidocaine. Mexiletine and propafenon cannot be classified definitely on the basis of the hitherto available electrophysiological data. Besides their effects on the fast inward current these substances may have additional calcium antagonistic properties.

References

Feb 15, 1978·Klinische Wochenschrift·K Theisen
Sep 3, 1976·Deutsche medizinische Wochenschrift·E Aldor, H Heeger
Jan 1, 1977·Annual Review of Pharmacology and Toxicology·A Fleckenstein
Jun 19, 1978·European Journal of Clinical Pharmacology·G Koch, B Lindström
Nov 16, 1978·European Journal of Clinical Pharmacology·G Cocco, C Strozzi
Apr 1, 1978·Circulation·J L AndersonD C Harrison
Apr 1, 1978·The American Journal of Cardiology·E N MooreR A Moller
Jul 1, 1976·The American Journal of Cardiology·J Kupersmith
Apr 1, 1975·American Heart Journal·R G Talbot
Aug 25, 1973·Lancet·N P CampbellJ F Pantridge
Mar 1, 1974·American Heart Journal·B N Singh, O Hauswirth
Jan 1, 1971·Naunyn-Schmiedebergs Archiv Für Pharmakologie·H TritthartA Fleckenstein
Aug 1, 1974·The Journal of Physiology·L S Gettes, H Reuter
Jan 1, 1973·Circulation·P F CranefieldB F Hoffman
Dec 1, 1973·Journal of Pharmaceutical Sciences·B K YehB J Scherlag
May 1, 1974·European Journal of Pharmacology·F VerdonckA Vleugels
Jan 1, 1972·British Journal of Pharmacology·B N Singh, E M Vaughan Williams
Jun 1, 1966·American Heart Journal·A S Harris

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.